| Antigen | 12-aa peptide (designated NogoB21-P control peptide) within the N-terminus and at the splice site of Nogo-A from the putative extracellular domain of rat Nogo-B (1) was synthesized, conjugated to KLH |
| Form | Affinity purified IgG |
| Product Type | Primary Antibodies |
| SpCrossreactivity | The rat NogoB21-P peptide sequence was selected at the splice site of Nogo-A in a manner that the complete 12-aa NogoB21 epitope is only present in Nogo-B. This region in absent in Nogo-C. NogoB21-P is 100% conserved in mouse and 83% identical in human Nogo-B/Foocen-m/foocen-m2. Antibody crossreactivity of NogoB21 in various species is not established |
| SpeciesReactivity | Rat |
| SugApplications | Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the |
| SugNegativeControl | Non-immune Rabbit IgG Cat# 20009-1 |
| SugPositiveControl | Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid |
| SugSecAntibodies | http://4adi.com/commerce/ccc2480-secondary-antibodies-rabbit.htm |